Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The bacterial cell surface and membrane represent a critical structural and functional boundary essential for bacterial survival and pathogenesis (Silhavy et al., 2010). This target encompasses the cytoplasmic membrane, the peptidoglycan cell wall, and the outer membrane characteristic of Gram-negative bacteria (Nature Reviews Microbiology, 2010). Its primary biological functions include maintaining osmotic stability, providing structural rigidity, and acting as a selective permeability barrier for nutrient uptake and waste excretion (StatPearls, 2023). In the context of infectious diseases, these structures are vital for bacterial virulence, adhesion to host tissues, and protection against host immune responses (NIH, 2022). Many of the most successful classes of antibiotics, such as beta-lactams and glycopeptides, target the biosynthesis of the peptidoglycan layer, leading to cell lysis (PubMed, 2021). Other agents, like polymyxins and lipopeptides, directly interact with and disrupt the lipid bilayer or lipopolysaccharide components, compromising membrane integrity (Journal of Antimicrobial Chemotherapy, 2007). Because certain components like peptidoglycan are absent in eukaryotic cells, these targets offer a high degree of selective toxicity, though the emergence of resistance remains a significant clinical challenge (WHO, 2023).
Inhibition of peptidoglycan cross-linking via penicillin-binding proteins (PBPs); binding to D-alanyl-D-alanine cell wall precursors; disruption of cytoplasmic membrane potential; detergent-like lysis of the outer membrane via lipopolysaccharide binding (Kohanski et al., 2010; StatPearls, 2023).
9 more in the full profile.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Bacterial cell surface and membrane.